Company profile · Investeringsmaatschappij / fonds
Aglaia Oncology Funds
- Biotechnology
- Investeringsmaatschappij / fonds
- Bilthoven
- Biotechnology · Bilthoven
- Employees
- 2–10
- Founded
- 2003
- Province
- Utrecht
- Country
- Netherlands
About Aglaia Oncology Funds
Aglaia is an investment fund fully focused on the fight against cancer and the development of improved anti-cancer drugs in particular. Aglaia has a proven ability to select and mature early-stage breakthrough inventions that have the potential to transform cancer treatment.
For more information, please visit www.aglaia-oncology.com
Address
Headquarters
Prof. Bronkhorstlaan 10-923723MB BilthovenUtrecht, Netherlands
Team by function
Based on 6 public job profiles as of 4 September 2026.
- Other / Unclassifiable3
- Executive / C-Suite1
- Finance / Accounting1
- Healthcare / Medical1
Similar companies
Companies with a similar profile, Utrecht first.
Oncode Accelerator
Research · Utrecht
11–50 employeesView profile
Cleara Biotech B.V.
Biotechnology · Utrecht
2–10 employeesView profile
Abvion
Biotechnology · Utrecht
2–10 employeesView profile
Altaica Capital
Investment Management · Utrecht
2–10 employeesView profile
Oncode Institute
Research · Utrecht
11–50 employeesView profile
FFUND - Life Science and Health consulting
Financial Services · Abcoude
11–50 employeesView profile